Developer docs
API playgroundTry for free, no card

Search company profiles

Novela Neurotech

Full company profile

uuid0003ssd

Namestring
Novela Neurotech
Legal namestring
Novela Neurotechnologies Inc.
Websiteurl
neureka.ai
Company typeenum
Private
Founded yearint
2018
Short descriptiontext

Novela Neurotech develops the Neureka® epilepsy care platform, integrating FDA-cleared wearable technology (SeizureLink™ and SPEAC®) for continuous seizure monitoring, serving epilepsy patients and neurology healthcare providers in the United States.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersAlameda, United States
HQ citystring
Alameda
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
epilepsy care platform, seizure monitoring, wearable neurotechnology, neurological diagnostics, FDA-cleared wearables
Industry4 codes
PRIMARYHLAHACAE
Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLALAGAC
Neurology Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)
SECONDARYHLACAFAL
Connected Therapeutics & Smart Drug Delivery Monitoring
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms
SECONDARYHLAKAIAB
Epilepsy & Seizure Disorders
NAICS code3 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing3345
  • Medical Equipment and Supplies Manufacturing3391
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Surgical & Medical Instruments & Apparatus3841
Product category
Epilepsy Care Technology
Social media profiles1 record
Cost components5 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 3 records shown
1Neureka®
Description

Epilepsy care platform developed by Novela Neurotechnologies for seizure diagnosis and detection through FDA-cleared wearables.

einpresswire.com
+2 more records
Core offering1 text field

Novela Neurotech develops and operates the Neureka® epilepsy care platform, which delivers continuous seizure monitoring and diagnostic support using FDA-cleared wearable technology. The company sells the SeizureLink™ wearable and the SPEAC® System—both acquired through the 2022 Brain Sentinel IP acquisition—as integrated components of its platform for epilepsy diagnosis and seizure detection.

Differentiator
Functional benefit
Problem solved
Product and service3 records
1Neureka®
CategoryEpilepsy Care Platform
Description

Flagship epilepsy care platform from Novela Neurotech providing continuous monitoring and seizure detection through FDA-cleared wearable technology, intended for use by healthcare providers managing epilepsy patients.

2SeizureLink™ Wearable
CategoryWearable Neurotechnology
Description

Wearable device for seizure detection and monitoring, acquired as part of the Brain Sentinel Inc. intellectual property portfolio and integrated into Novela's Neureka® epilepsy care platform for continuous monitoring.

3SPEAC® System
CategorySeizure Monitoring System
Description

FDA-cleared seizure monitoring system acquired from Brain Sentinel Inc. and integrated into Novela's Neureka® epilepsy care platform to enhance diagnostic and continuous monitoring capabilities.

Partnership1 partner
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2022-06-01
Description

Novela Neurotechnologies Inc. acquired the intellectual property of Brain Sentinel Inc., including patents and the SeizureLink™ wearable and SPEAC® System. This acquisition was made to advance Novela's epilepsy care platform Neureka®, enhancing the company's ability to diagnose and detect seizures through FDA-cleared wearables that provide continuous monitoring.

Peers10 records
TypeDirect peer
Description

Empatica makes the EpiMonitor (formerly Embrace2) wearable, an FDA-cleared smartwatch for seizure detection in epilepsy patients. It is the most direct functional peer to Novela's SeizureLink/SPEAC wearable-monitor approach and competes for the same neurologist-prescribed channel.

TypeDirect peer
Description

NeuroPace commercializes the RNS® System, a closed-loop neurostimulator that continuously monitors and responds to seizure activity. While implantable rather than wearable, NeuroPace addresses the same refractory-epilepsy population and competes for neurology share-of-mind and reimbursement.

TypeEmerging player
Description

Epitel develops wearable, point-of-care and long-term EEG sensors (e.g., the Epitel patch) for seizure detection and monitoring. Its wireless, disposable EEG patch overlaps directly with Novela's continuous-monitoring value proposition in ambulatory epilepsy care.

TypeEmerging player
Description

UNEEG produces the 24/7 EEG™ SubQ subcutaneous EEG implant for long-term seizure monitoring in epilepsy. It overlaps with Novela on the continuous-EEG-monitoring use case for refractory epilepsy patients.

TypeBroad incumbent
Description

Ceribell makes the point-of-care cloud-linked EEG system used in hospitals for rapid seizure and neurological-status assessment. It is a broader neuro-monitoring incumbent whose AI-enabled EEG platform competes with Novela for neurologist mindshare, especially in the inpatient-adjacent segments.

TypeBroad incumbent
Description

Natus manufactures a wide range of neurodiagnostic equipment, including EEG systems used in epilepsy evaluation. As an established neurodiagnostic incumbent, it represents the legacy-channel competitor that Novela must displace or partner with to reach neurology customers.

TypeBroad incumbent
Description

Masimo offers patient-monitoring and connectivity solutions (including SedLine brain monitoring and hospital-wide monitoring platforms). While broader than epilepsy, Masimo represents the convergence of wearable sensors, AI signal processing, and clinical decision support that Novela's platform aspires to in neurology.

TypeBroad incumbent
Description

Medtronic's Brain Therapies division includes deep brain stimulation and intraoperative/neuro monitoring products touching the epilepsy and neurology ecosystem. As a large medtech incumbent, it is a credible acquirer or channel partner and shapes pricing dynamics for novel neurology devices.

TypeEmerging player
Description

iMediSync develops AI-enabled EEG analysis tools and wearable brain-mapping hardware. Its overlap is in the intersection of EEG hardware and AI-driven seizure/neurology analytics, paralleling Novela's wearable-plus-software platform approach.

TypeEmerging player
Description

Zeto makes a wireless, dry-electrode EEG headset with cloud-based review and AI seizure-detection features. It is an emerging player offering a portable, easy-to-deploy EEG platform targeting similar ambulatory neurology and seizure-monitoring workflows as Novela.

Market position
Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability1 record

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Novela Neurotech

Epilepsy Care Technologyneureka.ai

Novela Neurotech develops the Neureka® epilepsy care platform, integrating FDA-cleared wearable technology (SeizureLink™ and SPEAC®) for continuous seizure monitoring, serving epilepsy patients and neurology healthcare providers in the United States.

Novela Neurotech firmographics

Firmographics
Name
Novela Neurotech
Legal name
Novela Neurotechnologies Inc.
Website
https://neureka.ai
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
1–10 employees
Short description
Novela Neurotech develops the Neureka® epilepsy care platform, integrating FDA-cleared wearable technology (SeizureLink™ and SPEAC®) for continuous seizure monitoring, serving epilepsy patients and neurology healthcare providers in the United States.
Ownership category
akta.pro rank

Novela Neurotech industry classification

Industry
Product category
Epilepsy Care Technology
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345), Medical Equipment and Supplies Manufacturing (3391)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHACAE
Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLALAGAC
Neurology Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)
SECONDARYHLACAFAL
Connected Therapeutics & Smart Drug Delivery Monitoring
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms
SECONDARYHLAKAIAB
Epilepsy & Seizure Disorders

Keywords

  • Epilepsy care platform
  • Seizure monitoring
  • Wearable neurotechnology
  • Neurological diagnostics
  • FDA-cleared wearables

Where Novela Neurotech is headquartered

Location

Headquarters

HQ city
Alameda
HQ country
United States
HQ region
North America

Markets served

Novela Neurotech business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain

Novela Neurotech product offering

Product offering

Core offering

Novela Neurotech develops and operates the Neureka® epilepsy care platform, which delivers continuous seizure monitoring and diagnostic support using FDA-cleared wearable technology. The company sells the SeizureLink™ wearable and the SPEAC® System—both acquired through the 2022 Brain Sentinel IP acquisition—as integrated components of its platform for epilepsy diagnosis and seizure detection.

Differentiator

Problem solved

Functional benefit

Brands

  • Neureka®: Epilepsy care platform developed by Novela Neurotechnologies for seizure diagnosis and detection through FDA-cleared wearables.
  • SeizureLink™
  • SPEAC® System

Products and services

  • Neureka® Flagship epilepsy care platform from Novela Neurotech providing continuous monitoring and seizure detection through FDA-cleared wearable technology, intended for use by healthcare providers managing epilepsy patients.
  • SeizureLink™ Wearable Wearable device for seizure detection and monitoring, acquired as part of the Brain Sentinel Inc. intellectual property portfolio and integrated into Novela's Neureka® epilepsy care platform for continuous monitoring.
  • SPEAC® System FDA-cleared seizure monitoring system acquired from Brain Sentinel Inc. and integrated into Novela's Neureka® epilepsy care platform to enhance diagnostic and continuous monitoring capabilities.

Companies that use Novela Neurotech

Customer profile

Segments2 records

Ideal customer profiles2 records

Novela Neurotech technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature3 records

Novela Neurotech partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Brain Sentinel Inc.coreTechnology or Integration · 1 June 2022Novela Neurotechnologies Inc. acquired the intellectual property of Brain Sentinel Inc., including patents and the SeizureLink™ wearable and SPEAC® System. This acquisition was made to advance Novela's epilepsy care platform Neureka®, enhancing the company's ability to diagnose and detect seizures through FDA-cleared wearables that provide continuous monitoring.

Novela Neurotech competitors and assessment

Company assessment

Direct peers

  • Empatica: Empatica makes the EpiMonitor (formerly Embrace2) wearable, an FDA-cleared smartwatch for seizure detection in epilepsy patients. It is the most direct functional peer to Novela's SeizureLink/SPEAC wearable-monitor approach and competes for the same neurologist-prescribed channel.
  • NeuroPace: NeuroPace commercializes the RNS® System, a closed-loop neurostimulator that continuously monitors and responds to seizure activity. While implantable rather than wearable, NeuroPace addresses the same refractory-epilepsy population and competes for neurology share-of-mind and reimbursement.

Emerging players

  • Epitel: Epitel develops wearable, point-of-care and long-term EEG sensors (e.g., the Epitel patch) for seizure detection and monitoring. Its wireless, disposable EEG patch overlaps directly with Novela's continuous-monitoring value proposition in ambulatory epilepsy care.
  • UNEEG Medical: UNEEG produces the 24/7 EEG™ SubQ subcutaneous EEG implant for long-term seizure monitoring in epilepsy. It overlaps with Novela on the continuous-EEG-monitoring use case for refractory epilepsy patients.
  • iMediSync: iMediSync develops AI-enabled EEG analysis tools and wearable brain-mapping hardware. Its overlap is in the intersection of EEG hardware and AI-driven seizure/neurology analytics, paralleling Novela's wearable-plus-software platform approach.
  • Zeto: Zeto makes a wireless, dry-electrode EEG headset with cloud-based review and AI seizure-detection features. It is an emerging player offering a portable, easy-to-deploy EEG platform targeting similar ambulatory neurology and seizure-monitoring workflows as Novela.

Broad incumbents

  • Ceribell: Ceribell makes the point-of-care cloud-linked EEG system used in hospitals for rapid seizure and neurological-status assessment. It is a broader neuro-monitoring incumbent whose AI-enabled EEG platform competes with Novela for neurologist mindshare, especially in the inpatient-adjacent segments.
  • Natus Medical: Natus manufactures a wide range of neurodiagnostic equipment, including EEG systems used in epilepsy evaluation. As an established neurodiagnostic incumbent, it represents the legacy-channel competitor that Novela must displace or partner with to reach neurology customers.
  • Masimo: Masimo offers patient-monitoring and connectivity solutions (including SedLine brain monitoring and hospital-wide monitoring platforms). While broader than epilepsy, Masimo represents the convergence of wearable sensors, AI signal processing, and clinical decision support that Novela's platform aspires to in neurology.
  • Medtronic: Medtronic's Brain Therapies division includes deep brain stimulation and intraoperative/neuro monitoring products touching the epilepsy and neurology ecosystem. As a large medtech incumbent, it is a credible acquirer or channel partner and shapes pricing dynamics for novel neurology devices.

Market position

Customer concentration

Novela Neurotech social profiles

Digital presence

Novela Neurotech financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Novela Neurotech leadership team

Management profile

Number of profiles

Profiles2 records

Novela Neurotech funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Novela Neurotech M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Novela Neurotech

What does Novela Neurotech do?

Novela Neurotech develops and operates the Neureka® epilepsy care platform, which delivers continuous seizure monitoring and diagnostic support using FDA-cleared wearable technology. The company sells the SeizureLink™ wearable and the SPEAC® System—both acquired through the 2022 Brain Sentinel IP acquisition—as integrated components of its platform for epilepsy diagnosis and seizure detection.

Is Novela Neurotech a public or private company?

Novela Neurotech is a private company. It is classified as unknown and is currently operating.

When was Novela Neurotech founded?

Novela Neurotech was founded in 2018. It employs 1 to 10 people.

Where is Novela Neurotech based?

Novela Neurotech is headquartered in Alameda, United States, in the North America region.

Who are Novela Neurotech's main competitors?

Direct peers on record are Empatica and NeuroPace. Emerging players are Epitel, UNEEG Medical, iMediSync and Zeto. Broad incumbents are Ceribell, Natus Medical, Masimo and Medtronic.

Does Novela Neurotech have an API?

No public API is recorded for Novela Neurotech.

What industry is Novela Neurotech in?

Novela Neurotech's product category is Epilepsy Care Technology. Its primary akta.pro industry code is HLAHACAE, Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables), with a secondary code of HLALAGAC, Neurology Telemedicine Platforms. Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
RepublicNeureka® for EpilepsyRepublic hosted a Regulation Crowdfunding offering for Novela Neurotechnologies, Inc., which closed on April 16, 2023. The campaign aimed to raise capital for the company's Neureka AI-powered wearable devices designed for epilepsy care and SUDEP monitoring. The offer specified a funding goal of $1.24 million with a valuation cap of $25 million.EIN PresswireNovela Neurotechnologies Acquires 510(k)-Cleared Seizure-Detection Assets from Brain SentinelNovela Neurotechnologies Inc. has acquired the complete intellectual property portfolio of Brain Sentinel Inc., including 58 patents related to seizure detection technology on June 1, 2022. This acquisition enhances Novela's Neureka® platform with advanced capabilities for continuous, data-driven epilepsy care. The integration of Brain Sentinel's FDA-cleared wearables is expected to significantly improve patient diagnosis and management of seizures.News-MedicalNovela Neurotech’s “smart” neural interface displayed at Creative Destruction LabNovela Neurotech, a MedTech company, showcased its AI-powered wireless neural interface at the Creative Destruction Lab on December 11th, 2019. The device aims to provide targeted electrical stimulation to treat neurological disorders such as depression, addiction, and epilepsy, leveraging advanced microfabrication technologies. The company seeks to accelerate neurological treatment development through its Neureka platform, facilitating data collection and collaboration among specialists.